Wednesday, March 22, 2023
HomePress ReleaseEIN PresswireU.S Non Invasive Prenatal Testing Market to Hit US$ 2,557 Million at...

U.S Non Invasive Prenatal Testing Market to Hit US$ 2,557 Million at CAGR 13.9% During Forecasts Period 2022-2030


non-invasive-prenatal-testing-market

DPI Research published a report titled “U.S. NIPT Testing Market ” report which covers comprehensive data on market dynamics of the United States industry.

NEW DELHI, DELHI, INDIA, March 21, 2022 /EINPresswire.com/ — Amid the COVID-19 crisis, the United States market for non invasive prenatal testing (NIPT) estimated at US$ 788 million in the year 2021, is expected to reach a revised market size of US$ 2,557 Million by 2030, growing at a CAGR of 13.9% over the period 2021 – 2030.

The Prominent Factors that are Expected to Contribute to the Growth of the United States Non-Invasive Prenatal Testing Market During the Forecast Period:

increase in incidences of chromosomal aneuploidies among fetus

progress of advanced non-invasive prenatal testing products

rising adoption regarding non-invasive prenatal testing

growing focus on reimbursement for non-invasive prenatal testing

increasing preference for non-invasive techniques over invasive methods

ACOG guidelines recommend NIPT for all pregnancies regardless of risk

After conducting thorough research on the historical and current growth parameters, the growth prospects of the United States non-invasive prenatal testing (NIPT) market are obtained with maximum precision.

This new 2022 market report provides a holistic analysis of the entire United States non-invasive prenatal testing market. The report offers the most up–to–date industry data on the actual market situation and future outlook for the United States’ non-invasive prenatal testing market. The report also provides up–to–date historical market size data for the period 2018 – 2021 and an illustrative forecast to 2030 covering key market aspects like market value and volume for non-invasive prenatal testing in the United States.

The report also includes the latest insights on comparative test analysis by companies. The following points are covered in the comparative test analysis: technology, fetal fraction, starting week, twin, sex chromosome aneuploidy, gender, deletion/duplication, triploidy, turnaround time, egg donor, accuracy, and many more.

Additionally, this up-to-date report describes the latest features reimbursement pattern and offers a clear view of the regulatory framework of the United States non–invasive prenatal testing market.

The report also tracks and analyses competitive developments, including collaboration deals, mergers & acquisitions, venture capital investment, distribution, exclusive and licensing agreements, and partnerships deals.

The report also covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market.

The report will serve as a source for a 360-degree analysis, thoroughly integrating different models.

This Newest and Comprehensive the United States Non-Invasive Prenatal Testing Market Research Report 2022 Delivers:

Comprehensive Research Methodology of the United States Non-Invasive Prenatal Testing Market

The report includes a Detailed and Extensive Market Overview with Key Analyst Insights

Insights about market determinants that are stimulating the United States Non-Invasive Prenatal Testing Market

To Analyse the Historical Growth in the Market Size of the United States Non–Invasive Prenatal Testing Market from 2018 to 2021

To Estimate and Forecast the Market Size of the United States Non–Invasive Prenatal Testing Market from 2022 to 2030 and Growth Rate until 2030

The Market Size of the United States Average Risk Non–Invasive Prenatal Testing Market with Eight Years Forecast

The Market Size of the United States High-Risk Non–Invasive Prenatal Testing Market with Eight Years Forecast

Evaluates the Number of NIPT Tests Performed in the United States with Eight Years Forecast

Studies the United States Number of Average Risk NIPT Tests Performed with Eight Years Forecast

Examines the United States Number of High-Risk NIPT Tests Performed with Eight Years Forecast

Assessment of Market Potential and Opportunities for this Innovation-Driven United States Non–Invasive Prenatal Testing Market with Eight Years Forecast

Insights into the United States Average and High-Risk Potential NIPT Tests Market with Eight Years Forecast

Meticulously Assesses the Overall United States Potential Non–Invasive Prenatal Testing (NIPT) Volume and Future Trends

Analyses of the United States Average and High-Risk Potential Number of Tests Performed with Eight Years Forecast

Detailed Insights into the Regulatory Framework of the United States Non–Invasive Prenatal Testing Market

Features Reimbursement Patterns of the United States Non–Invasive Prenatal Testing Market

Tracks Competitive Developments, Approaches, Recent Industry Developments, Mergers & Acquisitions, Collaboration Deals, Partnership Deals, Distribution, Exclusive, and Licensing Agreement

Extensive Profiles and Recent Developments of 12 Market Players.

The Key Market Players for the United States Non–Invasive Prenatal Testing Market are Listed Below:

Illumina, Inc.

Natera, Inc.

Quest Diagnostics

Myriad Genetics, Inc.

Centogene

GenPath

PerkinElmer

Yourgene Health

Invitae Corporation

Agilent Technologies

Ariosa Diagnostics (Roche)

Laboratory Corporation of America Holdings

Key Questions Answered in this Report: Non Invasive Prenatal Testing Market:

What is the current scenario of the united states non–invasive prenatal testing market?

What is the total market size and forecast (until 2030) for the united states non–invasive prenatal testing market?

How big is the united states NIPT tests market?

Which is the best non-invasive prenatal test?

How has the potential market performed so far and how will it perform in the coming years?

How many NIPT tests are being performed in the united states during 2018 – 2030?

What is the market size of the average risk NIPT tests in the united states?

What is the market size of the high-risk NIPT tests in the united states?

What are the key marketed NIPT tests available in the united states?

What are the major drivers of the united states non–invasive prenatal testing market?

What are the major inhibitors of the united states non–invasive prenatal testing market?

What is the reimbursement pattern in the united states non–invasive prenatal testing market?

What is the regulatory framework in the united states non–invasive prenatal testing market?

What are the major deals and agreement happenings in the united states non–invasive prenatal testing market?

What companies offer NIPT tests in the united states?

Who are the top market players? What are their happenings, current developments, and scenarios?

How is the market predicted to develop in the future?

The report is readily available and can be dispatched immediately after payment confirmation.

Would like to place an order or any questions, please feel free to contact at sales@dpiresearch.com

More Information about this report : https://dpiresearch.com/us-non-invasive-prenatal-testing-nipt-2022-2030/

Maria Rai
DPI Research
+91 76676 48693
sales@dpiresearch.com
Visit us on social media:
Facebook
Twitter
LinkedIn
Other

Non Invasive Prenatal Genetic Testing Market | Pregnancy Birth and Baby





Source link

RELATED ARTICLES

Most Popular